Editas Medicine, Inc.
EDIT
21 insider filings · Latest: Sep 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | Sep 4 8:27 PM | Linda BurklyEVP, CHIEF SCIENTIFIC OFFICER | Sale | 709 | $3.04 | $2.2K | 61,660(D) | View → |
| Sep 3, 2026 | Sep 4 8:25 PM | Amy ParisonSVP, Chief Financial Officer | Sale | 453 | $3.04 | $1.4K | 13,839(D) | View → |
| Sep 3, 2026 | Sep 4 8:22 PM | Gilmore Neil O'NeillDirector, CEO | Sale | 5,124 | $3.04 | $15.6K | 243,189(D) | View → |
| Sep 3, 2026 | Aug 31 8:11 PM | O'Neill Gilmore Neil | Proposed Sale | 5,100 | $3.28 | $16.7K | — | View → |
| Sep 3, 2026 | Aug 31 8:09 PM | Burkly Linda | Proposed Sale | 700 | $3.28 | $2.3K | — | View → |
| Aug 3, 2026 | Aug 5 8:07 PM | Amy ParisonSVP, Chief Financial Officer | Sale | 678 | $2.58 | $1.7K | 14,292(D) | View → |
| Jul 28, 2026 | Jul 29 8:51 PM | Linda BurklyEVP, CHIEF SCIENTIFIC OFFICER | Sale | 4,928 | $2.67 | $13.2K | 62,369(D) | View → |
| Jul 27, 2026 | Jul 21 8:37 PM | Burkly Linda | Proposed Sale | 5,500 | $2.88 | $15.8K | — | View → |
| Jun 3, 2026 | Jun 5 8:33 PM | Amy ParisonSVP, Chief Financial Officer | Sale | 464 | $2.70 | $1.3K | 14,970(D) | View → |
| Jun 3, 2026 | Jun 5 8:33 PM | Gilmore Neil O'NeillDirector, CEO | Sale | 15,380 | $2.70 | $41.5K | 248,313(D) | View → |
| Jun 3, 2026 | Jun 5 8:32 PM | Linda BurklyEVP, CHIEF SCIENTIFIC OFFICER | Sale | 731 | $2.70 | $2.0K | 67,297(D) | View → |
| Jun 3, 2026 | May 29 8:40 PM | O'Neill Gilmore Neil | Proposed Sale | 15,000 | $3.08 | $46.2K | — | View → |
| Mar 3, 2026 | Mar 4 9:56 PM | Gilmore Neil O'NeillDirector, CEO | Sale | 5,394 | $2.02 | $10.9K | 263,693(D) | View → |
| Mar 3, 2026 | Mar 4 9:49 PM | Amy ParisonSVP, Chief Financial Officer | Sale | 474 | $2.02 | $957 | 15,434(D) | View → |
| Mar 3, 2026 | Mar 4 9:48 PM | Linda BurklyEVP, CHIEF SCIENTIFIC OFFICER | Sale | 749 | $2.02 | $1.5K | 68,028(D) | View → |
| Mar 3, 2026 | Feb 27 9:35 PM | O'Neill Gilmore Neil | Proposed Sale | 6,000 | $1.89 | $11.3K | — | View → |
| Dec 3, 2025 | Dec 1 10:06 PM | O'Neill Gilmore Neil | Proposed Sale | 7,000 | $2.50 | $17.5K | — | View → |
| Sep 3, 2025 | Aug 29 8:34 PM | O'Neill Gilmore Neil | Proposed Sale | 7,000 | $2.73 | $19.1K | — | View → |
| Sep 3, 2025 | Aug 29 8:22 PM | Burkly Linda | Proposed Sale | 800 | $2.73 | $2.2K | — | View → |
| Jul 31, 2025 | Jul 30 8:15 PM | Burkly Linda | Proposed Sale | 7,500 | $3.46 | $25.9K | — | View → |
Page 1 of 2
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Sep 9 8:58 PM | Daniel Scott OryEVP, Chief Medical Officer | Grant/Award | 950,000 | $3.03 | 950,000(D) | View → |
| Aug 6, 2026 | Aug 7 9:16 PM | Patrick Thomas Ellinor IIDirector | Grant/Award | 103,400 | $2.90 | 103,400(D) | View → |
| Jun 17, 2026 | Jun 22 8:31 PM | Bernadette ConnaughtonDirector | Grant/Award | 51,700 | $2.55 | 51,700(D) | View → |
| Jun 17, 2026 | Jun 22 8:30 PM | Jessica HopfieldDirector | Grant/Award | 51,700 | $2.55 | 51,700(D) | View → |
| Jun 17, 2026 | Jun 22 8:30 PM | Andrew HirschDirector | Grant/Award | 51,700 | $2.55 | 51,700(D) | View → |
| Jun 17, 2026 | Jun 22 8:29 PM | David ScaddenDirector | Grant/Award | 51,700 | $2.55 | 51,700(D) | View → |
| Jun 17, 2026 | Jun 22 8:28 PM | Elliott M. LevyDirector | Grant/Award | 51,700 | $2.55 | 51,700(D) | View → |
| Mar 12, 2026 | Mar 16 8:37 PM | Gilmore Neil O'NeillDirector, CEO | Grant/Award | 1,015,200 | $2.54 | 1,015,200(D) | View → |
| Mar 12, 2026 | Mar 16 8:35 PM | Amy ParisonSVP, Chief Financial Officer | Grant/Award | 292,856 | $2.54 | 292,856(D) | View → |
| Mar 12, 2026 | Mar 16 8:34 PM | Linda BurklyEVP, CHIEF SCIENTIFIC OFFICER | Grant/Award | 292,856 | $2.54 | 292,856(D) | View → |